Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors
Science Advances · 21.04.2023 · 9 (16)
DOI: 10.1126/sciadv.adg6618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 21.04.2023. Verfasst von Timothy F Shay und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Carbonic Anhydrase IV. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
The blood-brain barrier (BBB) presents a major challenge for delivering large molecules to study and treat the central nervous system. This is due in part to the scarcity of targets known to mediate BBB crossing. To identify novel targets, we leverage a panel of adeno-associated viruses (AAVs) previously identified through mechanism-agnostic directed evolution for improved BBB transcytosis. Screening potential cognate receptors for enhanced BBB crossing, we identify two targets: murine-restricted LY6C1 and widely conserved carbonic anhydrase IV (CA-IV). We apply AlphaFold-based in silico methods to generate capsid-receptor binding models to predict the affinity of AAVs for these identified receptors. Demonstrating how these tools can unlock target-focused engineering strategies, we create an enhanced LY6C1-binding vector, AAV-PHP.eC, that, unlike our prior PHP.eB, also works in Ly6a -deficient mouse strains such as BALB/cJ. Combined with structural insights from computational modeling, the identification of primate-conserved CA-IV enables the design of more specific and potent human brain–penetrant chemicals and biologicals, including gene delivery vectors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
- California State Polytechnic University, Pomona, Pomona, CA, USA.
ORCID-Profile: Timothy F Shay, Erin E Sullivan, Xiaozhe Ding, Xinhong Chen, Sripriya Ravindra Kumar, David Goertsen, David Brown, Jost Vielmetter, Máté Borsos, Damien A Wolfe, Annie W Lam, Viviana Gradinaru
Förderung
- NINDS NIH HHS
- NIMH NIH HHS
Zitieren
APA
Shay, T. F., Sullivan, E. E., Ding, X., Chen, X., Ravindra Kumar, S., Goertsen, D., Brown, D., Crosby, A., Vielmetter, J., Borsos, M., Wolfe, D. A., Lam, A. W., & Gradinaru, V. (2023). Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors. Science Advances, 9(16). https://doi.org/10.1126/sciadv.adg6618
Vancouver
Shay TF, Sullivan EE, Ding X, Chen X, Ravindra Kumar S, Goertsen D, et al. Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors. Science Advances. 2023;9(16). doi:10.1126/sciadv.adg6618
BibTeX
@article{Shay2023,
author = {Shay, Timothy F and Sullivan, Erin E and Ding, Xiaozhe and Chen, Xinhong and Ravindra Kumar, Sripriya and Goertsen, David and Brown, David and Crosby, Anaya and Vielmetter, Jost and Borsos, Máté and Wolfe, Damien A and Lam, Annie W and Gradinaru, Viviana},
title = {Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {16},
doi = {10.1126/sciadv.adg6618}
}
EUVIMED